Navigation Links
Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference

, +1-713-798-7637, loriw@bcm.edu

Web site: http://www.medivation.com/

Ticker Symbol: (AMEX:MDV)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone

Post Your Comments:
(Date:11/25/2009)...Newswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),...rminimallydisruptivesurgicaltreatmentsforthespine,...y,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfe...sementfortheCompany,sproductsandwillincludecomment...ssion.Thedial-innumbersare1-877-407-4018fordomesti...
(Date:11/25/2009)...dSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareInt...ovatorandprovideroflessinvasive,miniaturizedcircul...tofadvancedheartfailure,todayannouncedthatitissche...perJaffrayHealthCareConferenceat8:00amESTonWednesd...YorkPalaceHotel,December1-2. ,, Alivewebcastoft...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--QuestDiagnosticsIncorpora...tictesting,informationandservices,announcedthatiti...careConferenceinNewYorkCity.Thepresentationissched...me. ,, Duringtheconference,thecompanywillreaffi...peratingincometoexceed18%ofrevenues,anddilutedearn...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14 2009 56735 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 2NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 3NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 4
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
(Date:11/25/2009)...ire/--TheBartleHallConventionCenterwilltemporarily...enKansasCityhoststhelatestinaseriesofmassivefreecl...thasthepotentialtobethebiggestoneyet,becauseitwill...ysinsteadofoveraweekend,"SheriWood,executivedirect...NationalAssociationofFreeClinics(NAFC). ,, Atpr...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofbreastMR...teofnewleadingedgeclinicalapplicationsonitsAegis(T...ogicalSocietyofNorthAmerica(RSNA)annualmeetinginCh...ationsleveragetheuniquehighqualityimagesgeneratedb...ultipleimagingmodalitiesformulti-parametricassessm...
(Date:11/25/2009)...USNewswire/--TheBlackAIDSInstituterecentlyheldBoar...for2010. ,, ThenewBoardMembersareahighlydiverse...nance,governmenthealthprograms,editorial,andbusine...ofpersonalbackgroundsincludingbothheterosexualandg...representingmultipleagegroups. ,, (Photo: http:...
(Date:11/25/2009)...ancer who were treated with cisplatin-based chemot...rological side effects and Raynaud-like phenomena,...according to a new study published online November...te . , Marianne Brydy, M.D., of the Department o...en, Norway, and colleagues conducted a cross-secti...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ology says that it is possible to reduce high bloo... Scientists, in an attempt to study the effects of...lar responses, had found out the result from the r...lectro-puncture. Acupuncture is one of the t...
... laproscopic surgery, may require the use of a pul...ays a study published in the new issue of Archives...hat has a genetic component and often gets magnifi...ne of the most common procedures to control morbid...
... inner ear may restore partial hearing ability of ...n Nature Medicine. Scientists are of the ... regulatory gene called Atoh1 can be used to encou...cells of the inner ear are encouraged to change th...
...lic Health had found out that the intake of vitami...erosis (MS) in women. The study said that women wh...e of developing MS than the ones who did not take ...odern day treatment may slow the course of develop...
...like keratitis by wearing the latest silicone hydr...rnal// of Ophthalmology. Scientists showed th...ar or extended wear contact lenses have varied res...tudy and had used a clinical severity matrix to di...
...cer patients and people without liver cancer found...developing liver cancer compared to the general po...nt, such as demographics and major risk factors fo...cancer, may be boosting the risk even further. ...
Other Medicine News:
CRP FULL RANGE (0.1-160 mg/l)
Uric Acid (UA)
Apolipoprotein B (undiluted sample) Liquid
Urea (Kinetic) 3 minute read
Medicine Products: